Cerebrolysin-type neuropeptide complex is a preparation of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue through standardized biotechnological processing. The original Cerebrolysin, developed by EVER Neuro Pharma, has been used clinically in over 50 countries for stroke recovery, traumatic brain injury, and dementia management. Our analog provides a comparable neuropeptide profile for research applications in neuroscience and neuropharmacology. We supply this complex in lyophilized form for institutional research.
| Sequence | Complex mixture of neuropeptides and amino acids |
| Molecular Formula | Complex mixture |
| Molecular Weight | Variable (<10,000 Da) |
| Purity | ≥95% (total peptide/amino acid content) |
| Form | Lyophilized powder |
| Storage | -20°C, desiccated |
| CAS | 12656-61-0 |
Chen CC et al. (2013) demonstrated in Journal of the Neurological Sciences that Cerebrolysin-type neuropeptides promote neuroplasticity through BDNF and GDNF upregulation in post-stroke patients.
A Cochrane systematic review (2020) analyzed 6 randomized controlled trials involving Cerebrolysin in acute ischemic stroke, providing comprehensive safety and efficacy data.
Research published in Dementia and Geriatric Cognitive Disorders (2017) documented improvements in cognitive function scores following neuropeptide complex administration in Alzheimer's disease patients.
It is a standardized preparation of low-molecular-weight neuropeptides and free amino acids derived from porcine brain tissue. It mimics the composition profile of the clinical product Cerebrolysin and is intended for research use.
We supply this complex with ≥95% total peptide/amino acid content, verified by HPLC and amino acid analysis. As a natural complex, quality is assessed by total bioactive content and amino acid profile consistency.
Our research-grade analog follows similar production methodology but is manufactured specifically for research applications. It is not a registered pharmaceutical product and should not be used for clinical treatment.
MOQ depends on the quantity required. Contact our sales team for specific pricing and availability information.
Store at -20°C in lyophilized form. After reconstitution, store at 2-8°C and use within 7 days to maintain bioactivity of the neuropeptide components.
Nootropic peptide for cognitive enhancement and neuroprotection...
View Details Research PeptidesAnxiolytic peptide with immunomodulatory properties...
View Details Research PeptidesPeptide bioregulator for brain function improvement...
View Details Research PeptidesUltra-potent HGF mimetic for neuroscience research...
View Details